Chips and litigation headlines are shaping options flow this week. NVDA, MU, and META sit at the centre of the most active options desks.
NVDA topped news feeds after a blowout earnings report. Positive options bets on the stock ranked among the highest in the US large-cap universe over the past week. The stock is up 12% year-to-date. Analysts at Keybanc reiterated an Overweight rating with a $330 price target. ORTEX data shows analysts see a further 43% return potential from current levels. RSI sits at 46, leaving room to run.
MU led all large-caps in both positive and negative options bets over the last seven days. That two-sided surge in flow points to a market sharply divided on direction. The memory chip maker is up 229% year-to-date. ORTEX scores MU as a 90.8 out of 100 on its stock score — one of the highest in the semiconductor space. A headline flagged NVIDIA's biggest AI bottleneck as memory, putting MU squarely in focus.
META drew heavy options activity after agreeing a $17 billion settlement. The stock is down 13% this year. Its ORTEX stock score stands at 75.6. Analysts see 31% upside from current prices. The settlement removes a major legal overhang — options traders appear split on whether the relief is priced in.
TSLA also registered notable two-sided options flow. The stock is down 23% year-to-date. Its RSI of 49.8 sits at neutral. Significant negative bets have built up over the past week alongside renewed call buying — a pattern typical of traders hedging ahead of an expected catalyst.
Across the broader market, AMD and INTC saw positive options bets stack up. Both names are riding the AI memory and chip spend narrative alongside NVDA and MU.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
